NASDAQ · Financial Statements
Deciphera Pharmaceuticals, Inc. (DCPH) Financial Statements
$25.59
NASDAQ: DCPH
Market Cap $2.21B
Overview Financials Dividend Deciphera Pharmaceuticals, Inc. most recently reported annual revenue of $163.0M, net profit of $-195.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $25.0M $42.0M $96.0M $134.0M $163.0M Operating Profit $-201.0M $-271.0M $-300.0M $-183.0M $-211.0M Net Profit $-191.0M $-266.0M $-297.0M $-179.0M $-195.0M EPS $-4.47 $-4.78 $-5.11 $-2.37 $-2.29 Op Margin -802.9% -644.4% -312.1% -136.3% -129.1%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $622.0M $642.0M $429.0M $454.0M $474.0M Total Liabilities $76.0M $99.0M $125.0M $112.0M $123.0M Cash $120.0M $136.0M $87.0M $65.0M $84.0M Borrowings $18.0M $31.0M $31.0M $29.0M $26.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-149.0M $-240.0M $-241.0M $-153.0M $-147.0M Investing Cash Flow $-465.0M $23.0M $171.0M $-35.0M $12.0M Financing Cash Flow $436.0M $227.0M $15.0M $165.0M $152.0M Net Cash Flow $-173.0M $16.0M $-49.0M $-22.0M $19.0M Free Cash Flow $-154.0M $-245.0M $-247.0M $-154.0M $-147.0M
Valuation & Return Ratios
Metric Value PEG Ratio -3.93 EV / EBITDA -10.32 FCF Yield -6.66% Quick Ratio 3.59 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock